| A CFTR potentiator in patients with cystic fibrosis and the G551D mutation BW Ramsey, J Davies, NG McElvaney, E Tullis, SC Bell, P Dřevínek, ... New England Journal of Medicine 365 (18), 1663-1672, 2011 | 2514 | 2011 |
| The future of cystic fibrosis care: a global perspective SC Bell, MA Mall, H Gutierrez, M Macek, S Madge, JC Davies, PR Burgel, ... The Lancet Respiratory Medicine 8 (1), 65-124, 2020 | 933 | 2020 |
| ECFS best practice guidelines: the 2018 revision C Castellani, AJA Duff, SC Bell, HGM Heijerman, A Munck, F Ratjen, ... Journal of cystic fibrosis 17 (2), 153-178, 2018 | 805 | 2018 |
| European cystic fibrosis society standards of care: best practice guidelines AR Smyth, SC Bell, S Bojcin, M Bryon, A Duff, P Flume, N Kashirskaya, ... Journal of cystic fibrosis 13, S23-S42, 2014 | 789 | 2014 |
| Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals DJ Lederer, SC Bell, RD Branson, JD Chalmers, R Marshall, DM Maslove, ... Annals of the American Thoracic Society 16 (1), 22-28, 2019 | 672 | 2019 |
| Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial J Wolter, S Seeney, S Bell, S Bowler, P Masel, J McCormack Thorax 57 (3), 212-216, 2002 | 664 | 2002 |
| Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium JM Bryant, DM Grogono, D Rodriguez-Rincon, I Everall, KP Brown, ... Science 354 (6313), 751-757, 2016 | 560 | 2016 |
| A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised … MP Boyle, SC Bell, MW Konstan, SA McColley, SM Rowe, E Rietschel, ... The lancet Respiratory medicine 2 (7), 527-538, 2014 | 537 | 2014 |
| Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease R Khanna, S Bell, M Sherritt, A Galbraith, SR Burrows, L Rafter, B Clarke, ... Proceedings of the National Academy of Sciences 96 (18), 10391-10396, 1999 | 387 | 1999 |
| The rise of non-tuberculosis mycobacterial lung disease CN Ratnatunga, VP Lutzky, A Kupz, DL Doolan, DW Reid, M Field, ... Frontiers in immunology 11, 303, 2020 | 385 | 2020 |
| Genetic modifiers of liver disease in cystic fibrosis JR Bartlett, KJ Friedman, SC Ling, RG Pace, SC Bell, B Bourke, ... Jama 302 (10), 1076-1083, 2009 | 351 | 2009 |
| Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand AB Chang, SC Bell, CA Byrnes, K Grimwood, PW Holmes, PT King, ... Medical Journal of Australia 193, 356-365, 2010 | 327* | 2010 |
| Antibiotic Susceptibilities of Pseudomonas aeruginosa Isolates Derived from Patients with Cystic Fibrosis under Aerobic, Anaerobic, and Biofilm Conditions D Hill, B Rose, A Pajkos, M Robinson, P Bye, S Bell, M Elkins, ... Journal of clinical microbiology 43 (10), 5085-5090, 2005 | 284 | 2005 |
| Neutrophils in cystic fibrosis DG Downey, SC Bell, JS Elborn Thorax 64 (1), 81-88, 2009 | 277 | 2009 |
| New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls SC Bell, K De Boeck, MD Amaral Pharmacology & therapeutics 145, 19-34, 2015 | 255 | 2015 |
| Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical … SD Aaron, KL Vandemheen, W Ferris, D Fergusson, E Tullis, D Haase, ... The Lancet 366 (9484), 463-471, 2005 | 236 | 2005 |
| Development and reporting of prediction models: guidance for authors from editors of respiratory, sleep, and critical care journals DE Leisman, MO Harhay, DJ Lederer, M Abramson, AA Adjei, J Bakker, ... Critical care medicine 48 (5), 623-633, 2020 | 233 | 2020 |
| Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study HM Buntain, RM Greer, PJ Schluter, JCH Wong, JA Batch, JM Potter, ... Thorax 59 (2), 149-155, 2004 | 192 | 2004 |
| Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sources B De Smet, M Mayo, C Peeters, JEA Zlosnik, T Spilker, TJ Hird, JJ LiPuma, ... International Journal of Systematic and Evolutionary Microbiology 65 (Pt_7 …, 2015 | 189 | 2015 |
| Ex vivo monitoring of human cytomegalovirus‐specific CD8+ T‐cell responses using QuantiFERON®‐CMV S Walker, C Fazou, T Crough, R Holdsworth, P Kiely, M Veale, S Bell, ... Transplant Infectious Disease 9 (2), 165-170, 2007 | 188 | 2007 |
J Stuart ElbornImperial College and Royal Brompton Hospital, LondonEmail verificata su imperial.ac.uk
